XML 50 R33.htm IDEA: XBRL DOCUMENT v3.24.1
Note 13 - Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Fiscal Years

 

Stock-based compensation expense included in:

  2023   2022   2021 

Cost of revenue

 $328  $272  $282 

Research and development

  595   652   843 

Selling, general and administrative

  1,599   1,111   1,401 

Total costs and expenses

 $2,522  $2,035  $2,526 
  

Fiscal Years

 

Stock-based compensation expense by type of award:

 

2023

  

2022

  

2021

 

ESPP

 $127.00  $70.00  $110.00 

RSU and PRSU

  2,395   1,965   2,416 

Total costs and expenses

 $2,522  $2,035  $2,526 
Share-Based Payment Arrangement, Activity [Table Text Block]
  

Shares Available for Grant

 
    

Balance at January 2, 2022

  594 

Authorized

  900 

RSUs granted

  (584)

Options forfeited or expired

  18 

RSUs forfeited

  32 

Balance at January 1, 2023

  960 

Options forfeited or expired

  15 

RSUs granted

  (400)

RSUs forfeited

  20 

Balance at December 31, 2023

  595 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of Shares

  

Weighted Average Exercise Price

  

Weighted Average Remaining Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

  

(in thousands)

 

Balance outstanding at December 29, 2019

  186  $32.09         

Forfeited or expired

  (65)  38.83         

Balance outstanding at January 3, 2021

  121   28.46         

Forfeited or expired

  (28)  31.68         

Balance outstanding at January 2, 2022

  93   27.49         

Forfeited or expired

  (18)  39.72         

Balance outstanding at January 1, 2023

  75   24.50         

Forfeited or expired

  (15)  45.22         

Outstanding, exercisable, and vested at December 31, 2023

  60  $19.45   2.27  $86 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
  

RSUs Outstanding

 
  

Number of Shares

  

Weighted Average Grant Date Fair Value

 
  

(in thousands)

     

Nonvested at January 3, 2021

  800  $4.99 

Granted

  619   5.81 

Vested

  (586)  4.99 

Forfeited

  (265)  5.00 

Nonvested at January 2, 2022

  568   5.86 

Granted

  584   6.11 

Vested

  (490)  5.56 

Forfeited

  (32)  5.35 

Nonvested at January 1, 2023

  630   6.05 

Granted

  400   8.12 

Vested

  (421)  6.15 

Forfeited

  (20)  6.92 

Nonvested at December 31, 2023

  589  $7.35 
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
  

Fiscal Years

 
  

2023

  

2022

  

2021

 

Expected life (months)

  6.0   6.0   6.0 

Risk-free interest rate

  5.30%  3.04%  0.05%

Volatility

  50%  57%  74%

Dividend yield

         

Weighted average fair value of ESPP options granted

 $2.14  $2.04  $2.18